NEW YORK, Dec. 3-Large Scale Biology Corporation and Germany's Icon Genetics have signed an agreement with the Ukrainian government to develop plant-produced pharmaceuticals, LSBC said in a statement today.
The two companies plan to work with Ukrainian scientists to develop transgenic plants that can produce pharmaceutical quality proteins.
The Vice Prime Minister of Ukraine, Volodymyr Seminozhenko, signed a letter of intent with the two companies on November 5th, according to LSBC.
LSBC is developing a biomanufacturing process, Geneware, and claims to have built the world's first commercial scale plant pharmaceutical production center.
Icon Genetics, based in Munich, is working on agricultural biotechnology techniques.